1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > US Hematology Diagnostics Market

US Hematology Diagnostics Market

  • June 2014
  • -
  • Frost & Sullivan
  • -
  • 85 pages

Summary

Table of Contents

Longer Product Cycles Stall Market Growth

This research service analyzes and provides forecasts of the US hematology diagnostics market from 2012 to 2017. The market is broadly classified into 2 major segments: analyzers and reagents. The US hematology market was sized using a bottom-up revenue model developed from the actual installed base of hematology analyzers in US laboratories, the data for which were collected through an end-user survey. The number of hematology analyzers installed by manufacturer and model were collected from a sample population of more than 4,000 sites. The sample population included hospitals, reference laboratories, and physician’s office laboratories.

Methodology: The US hematology diagnostics market was sized using a bottom-up revenue model developed from the actual installed base of hematology analyzers in US laboratories collected through an end-user survey. The hematology analyzer installed base was extrapolated to the total US market. Installed base, company market share, and market forecasts were validated with primary and secondary sources. Primary interviews were conducted with individuals with the titles of global market manager and global business director. Secondary research included 2013 product guides from CAP Today, a College of American Pathologists publication; company reports; and proprietary databases.

Sample Population: The number of hematology analyzers installed by manufacturer and model were collected from a sample population of more than sites representing -% of the total US installed base. The sample population included hospitals, reference laboratories, and physician office laboratories (POLs).
Analyzer Models Included in Revenue Forecasts: The complete product list of hematology analyzers can be found in in the appendix.

Key Findings
-US hematology diagnostics market revenue was estimated at $ million in 2013 and is estimated to reach $ million by 2017. the market is expected to grow at a CAGR of %.
-The high-end hematology diagnostics market is mature with a limited innovation scope; it is dominated by 4 suppliers: Sysmex, Beckman Coulter (Danaher), Abbott Diagnostics, and Siemens Healthcare Diagnostics. Participants compete based on the number of parameters, reagents consumed, price, style, and customer service.
-Automated hematology analyzers play a vital role in transfusion medicine and in blood banks to screen donors and perform quality checks of blood samples—a key driver for the industry. Companies heavily invest in research and development (R&D) to cost-effectively offer more user-friendly and sophisticated models with more parameters.
-The high-end analyzer market (5PD and 3PD) sees the reagent offering as important because in vitro diagnostic (IVD) manufacturers often rely on the same reagents for lower-range systems. This can present a challenge to analyzer developers.
-The key to success lies in the process of integration and reagent development. Developers are actively working on know-how techniques to maximize gains.
-Mature markets such as the United States and Europe are still experiencing growth in test volumes due to aging populations and better accessibility and availability of testing services.
-Critical unmet needs and market challenges include market saturation, decreased hospital spending, and poor integration with laboratory information management systems (LIMS).

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 Competing in the Global Hematology and Flow Cytometry Markets

2017 Competing in the Global Hematology and Flow Cytometry Markets

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com contains 700 pages, 250 tables, and provides information not available from any other published source, including:  - Specimen forecasts by market segment- Test ...

2017-2021 Hematology and Flow Cytometry: Global Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2017-2021 Hematology and Flow Cytometry: Global Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 15900
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $34,500.DataPack (test volumes, sales forecasts, supplier shares) $15,900. Summary This comprehensive seven-country report contains 700 pages, 250 tables, and is designed to help current ...

2017 World Hematology and Flow Cytometry Market Future Horizons and Growth Strategies: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

2017 World Hematology and Flow Cytometry Market Future Horizons and Growth Strategies: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 15900
  • Industry report
  • March 2017
  • by Venture Planning Group

Complete report $34,500.DataPack (test volumes, sales forecasts, supplier shares) $15,900. Summary This comprehensive seven-country report contains 700 pages, 250 tables, and is designed to help current ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.